Skip to content

The role of resistant starch in the treatment of insulin resistance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN56997186
Enrollment
15
Registered
2010-05-19
Start date
2006-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Metabolic and Endocrine

Interventions

Participants are supplemented with either 40 g/day resistant starch (fibre) for 8 weeks compared to a placebo supplement which is energy matched. Study entry: single randomisation only

Sponsors

University of Surrey (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Non-diabetic 2. No history of cardiovascular, endocrine or gastrointestinal disease 3. Male and female over the age of 18 years 4. Fasting plasma insulin greater than 60 pmol/l

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Insulin sensitivity measured with hyperinsulinaemic euglycaemic clamp at end of each 8 week intervention.

Secondary

MeasureTime frame
1. mRNA expression in adipose tissue biopsies taken at end of each 8 week intervention 2. Postprandial meal handling and arteriovenous uptake of glucose measured at end of each 8 week intervention

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026